Zhangzhou Pien Tze Huang Pharmaceutical Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 2,886

Employees

  • Stock Symbol
  • 600436

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $19.29
  • (As of Friday Closing)

Zhangzhou Pien Tze Huang Pharmaceutical General Information

Description

Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include tablets, hard capsules, granules, pills (water pills, honey pills), syrups, tinctures (including external use), ointments, lozenges, decoctions, Chinese herbal medicine slices (including direct oral slices) (clean preparation); production of candy products (candy), health food products; and production of beverages (solid beverages).

Contact Information

Website
www.zzpzh.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Shang Street
  • Zhangzhou, Fujian 363000
  • China
+86 0596
Primary Industry
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Shang Street
  • Zhangzhou, Fujian 363000
  • China
+86 0596

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zhangzhou Pien Tze Huang Pharmaceutical Stock Performance

As of 20-Nov-2026, Zhangzhou Pien Tze Huang Pharmaceutical’s stock price is $19.29. Its current market cap is $11.6B with 603M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.29 $19.48 $15.59 - $25.31 $11.6B 603M 2.96M $0.32

Zhangzhou Pien Tze Huang Pharmaceutical Financials Summary

As of 30-Sep-2026, Zhangzhou Pien Tze Huang Pharmaceutical has a trailing 12-month revenue of $1.15B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 10,538,609 14,593,766 17,519,708 20,380,346
Revenue 1,147,381 1,251,705 1,503,439 1,421,720
EBITDA 221,718 372,084 506,463 489,617
Net Income 191,061 300,172 414,887 395,392
Total Assets 2,642,517 2,509,760 2,402,660 2,409,561
Total Debt 152,444 151,809 157,302 164,544
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zhangzhou Pien Tze Huang Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zhangzhou Pien Tze Huang Pharmaceutical‘s full profile, request access.

Request a free trial

Zhangzhou Pien Tze Huang Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories incl
Pharmaceuticals
Zhangzhou, China
2,886 As of 2025

Kunming, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zhangzhou Pien Tze Huang Pharmaceutical Competitors (1)

One of Zhangzhou Pien Tze Huang Pharmaceutical’s competitors is Yunnan Baiyao Group, a Corporation company based in Kunming, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Yunnan Baiyao Group Corporation Kunming, China
You’re viewing 1 of 1 competitors. Get the full list »

Zhangzhou Pien Tze Huang Pharmaceutical Patents

Zhangzhou Pien Tze Huang Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4692082-A1 Crystal form of 2,6-piperidinedione compound, and preparation method therefor and use thereof Pending 24-Mar-2023
US-20260265239-A1 Crystal form of 2,6-piperidinedione compound, and preparation method therefor and use thereof Pending 24-Mar-2023
WO-2024199147-A1 Crystal form of 2,6-piperidinedione compound, and preparation method therefor and use thereof Inactive 24-Mar-2023
JP-2026512830-A Crystalline form, manufacturing method, and use of 2,6-piperidinedione compounds Active 24-Mar-2023
JP-7881081-B2 Crystalline form, manufacturing method, and use of 2,6-piperidinedione compounds Active 24-Mar-2023 A61P35/00
To view Zhangzhou Pien Tze Huang Pharmaceutical’s complete patent history, request access »

Zhangzhou Pien Tze Huang Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zhangzhou Pien Tze Huang Pharmaceutical Acquisitions (1)

Zhangzhou Pien Tze Huang Pharmaceutical’s most recent deal was a Merger/Acquisition with Longhui Pharmaceutical for . The deal was made on 14-Jul-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Longhui Pharmaceutical 14-Jul-2020 Merger/Acquisition Pharmaceuticals
To view Zhangzhou Pien Tze Huang Pharmaceutical’s complete acquisitions history, request access »

Zhangzhou Pien Tze Huang Pharmaceutical ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

30.01 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Zhangzhou Pien Tze Huang Pharmaceutical’s complete esg history, request access »

Zhangzhou Pien Tze Huang Pharmaceutical Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Zhangzhou Pien Tze Huang Investment Management Zhangzhou, China 2022
Longhui Pharmaceutical Qiqihar, China 2005

Zhangzhou Pien Tze Huang Pharmaceutical FAQs

  • When was Zhangzhou Pien Tze Huang Pharmaceutical founded?

    Zhangzhou Pien Tze Huang Pharmaceutical was founded in 1999.

  • Where is Zhangzhou Pien Tze Huang Pharmaceutical headquartered?

    Zhangzhou Pien Tze Huang Pharmaceutical is headquartered in Zhangzhou, China.

  • What is the size of Zhangzhou Pien Tze Huang Pharmaceutical?

    Zhangzhou Pien Tze Huang Pharmaceutical has 2,886 total employees.

  • What industry is Zhangzhou Pien Tze Huang Pharmaceutical in?

    Zhangzhou Pien Tze Huang Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Zhangzhou Pien Tze Huang Pharmaceutical a private or public company?

    Zhangzhou Pien Tze Huang Pharmaceutical is a Public company.

  • What is Zhangzhou Pien Tze Huang Pharmaceutical’s stock symbol?

    The ticker symbol for Zhangzhou Pien Tze Huang Pharmaceutical is 600436.

  • What is the current stock price of Zhangzhou Pien Tze Huang Pharmaceutical?

    As of 20-Nov-2026 the stock price of Zhangzhou Pien Tze Huang Pharmaceutical is $19.29.

  • What is the current market cap of Zhangzhou Pien Tze Huang Pharmaceutical?

    The current market capitalization of Zhangzhou Pien Tze Huang Pharmaceutical is $11.6B.

  • What is Zhangzhou Pien Tze Huang Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Zhangzhou Pien Tze Huang Pharmaceutical is $1.15B.

  • Who are Zhangzhou Pien Tze Huang Pharmaceutical’s competitors?

    Yunnan Baiyao Group is a competitor of Zhangzhou Pien Tze Huang Pharmaceutical.

  • What is Zhangzhou Pien Tze Huang Pharmaceutical’s annual earnings per share (EPS)?

    Zhangzhou Pien Tze Huang Pharmaceutical’s EPS for 12 months was $0.32.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process